ES2101342T3 - TETRAZOLE DERIVATIVES SUBSTITUTED WITH PHOSPHONE. - Google Patents

TETRAZOLE DERIVATIVES SUBSTITUTED WITH PHOSPHONE.

Info

Publication number
ES2101342T3
ES2101342T3 ES93920310T ES93920310T ES2101342T3 ES 2101342 T3 ES2101342 T3 ES 2101342T3 ES 93920310 T ES93920310 T ES 93920310T ES 93920310 T ES93920310 T ES 93920310T ES 2101342 T3 ES2101342 T3 ES 2101342T3
Authority
ES
Spain
Prior art keywords
lower alkyl
carboxyl
formula
aryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93920310T
Other languages
Spanish (es)
Inventor
Lombaert Stephane De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/940,118 external-priority patent/US5273990A/en
Priority claimed from US07/959,000 external-priority patent/US5250522A/en
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2101342T3 publication Critical patent/ES2101342T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
    • A24D3/06—Use of materials for tobacco smoke filters
    • A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
    • A24D3/06—Use of materials for tobacco smoke filters
    • A24D3/16—Use of materials for tobacco smoke filters of inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F2/00—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof
    • D01F2/24—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from cellulose derivatives
    • D01F2/28—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from cellulose derivatives from organic cellulose esters or ethers, e.g. cellulose acetate

Abstract

The present invention relates to the N-phosphonomethyl substituted tetrazole derivatives of formula (I) and tautomers thereof wherein R0 represents (i) a group of formula (Ia) or (ii) a group of formula -X-COR3 (Ib); R and R' represent independently hydrogen, carbocyclic aryl, 6-tetrahydronaphthyl, 5-indanyl, (alpha)-(trichloromethyl, carboxyl, esterified carboxyl or amidated carboxyl) substituted-(lower alkyl or aryl-lower alkyl), acyloxymethyl optionally monosubstituted on methyl carbon by lower alkyl, by C5-C7-cycloalkyl, by aryl or by aryl-lower alkyl; R1 represents phenyl, or phenyl substituted by lower alkyl, lower alkoxy, halogen or trifluoromethyl; or R1 represents thienyl or furanyl optionally substituted by lower alkyl; or R1 represents hydrogen, if R0 represents a group of formula (Ia); R2 and R4 represent hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen or trifluoromethyl; n is 0, 1 or 2; COR3 carboxyl or carboxyl derivatized in form of a pharmaceutically acceptable ester; X represents a direct bond, C1-4-alkylene or C2-4-alkenylene; and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising said compounds; methods for preparation of said compounds and for the preparation of intermediates; and methods of treating disorders in mammals which are responsive to the inhibition of neutral endopeptidases by administration of said compounds to mammals in need of such treatment.
ES93920310T 1992-09-03 1993-08-24 TETRAZOLE DERIVATIVES SUBSTITUTED WITH PHOSPHONE. Expired - Lifetime ES2101342T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/940,118 US5273990A (en) 1992-09-03 1992-09-03 Phosphono substituted tetrazole derivatives
US07/959,000 US5250522A (en) 1992-10-09 1992-10-09 Phosphono/biaryl substituted amino acid derivatives

Publications (1)

Publication Number Publication Date
ES2101342T3 true ES2101342T3 (en) 1997-07-01

Family

ID=27130130

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93920310T Expired - Lifetime ES2101342T3 (en) 1992-09-03 1993-08-24 TETRAZOLE DERIVATIVES SUBSTITUTED WITH PHOSPHONE.

Country Status (16)

Country Link
EP (1) EP0660840B1 (en)
JP (1) JP3130938B2 (en)
KR (1) KR950702996A (en)
AT (1) ATE152727T1 (en)
AU (1) AU5089693A (en)
CA (1) CA2142348A1 (en)
DE (1) DE69310524T2 (en)
DK (1) DK0660840T3 (en)
ES (1) ES2101342T3 (en)
FI (1) FI950925A (en)
GR (1) GR3024314T3 (en)
HU (1) HUT72615A (en)
IL (1) IL106810A0 (en)
NO (1) NO950827L (en)
NZ (1) NZ255878A (en)
WO (1) WO1994005677A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583123A (en) * 1994-12-22 1996-12-10 Ciba-Geigy Corporation Certain tetrazole derivatives
US5550119A (en) * 1995-03-02 1996-08-27 Ciba-Geigy Corporation Phosphono substituted tetrazole derivatives as ECE inhibitors
US8673974B2 (en) * 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD141930A1 (en) * 1979-02-20 1980-05-28 Kurt Issleib PROCESS FOR THE PREPARATION OF N-PHOSPHONOMETHYLAMINOSAURES AND THEIR ESTERS
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives

Also Published As

Publication number Publication date
KR950702996A (en) 1995-08-23
EP0660840A1 (en) 1995-07-05
FI950925A0 (en) 1995-03-01
ATE152727T1 (en) 1997-05-15
IL106810A0 (en) 1993-12-08
NO950827L (en) 1995-06-09
AU5089693A (en) 1994-03-29
WO1994005677A1 (en) 1994-03-17
JP3130938B2 (en) 2001-01-31
JPH08501098A (en) 1996-02-06
NZ255878A (en) 1996-12-20
CA2142348A1 (en) 1994-03-17
FI950925A (en) 1995-03-01
HUT72615A (en) 1996-05-28
DK0660840T3 (en) 1997-07-14
DE69310524T2 (en) 1997-12-04
EP0660840B1 (en) 1997-05-07
GR3024314T3 (en) 1997-10-31
DE69310524D1 (en) 1997-06-12
NO950827D0 (en) 1995-03-02
HU9500648D0 (en) 1995-04-28

Similar Documents

Publication Publication Date Title
DK1642885T3 (en) Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for the treatment of inflammatory conditions of the gastrointestinal tract
KR910000658A (en) Imidazolyl-alkenoic acid
BR9104181A (en) COMPOUND
MX9804457A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation.
ES2197160T3 (en) BICYCLING FIBRONOGEN ANTAGONISTS.
IL154537A0 (en) 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
ATE327748T1 (en) ALKANDIOL DERIVATIVES FOR THE TREATMENT OF BONE DISEASES
EA200501104A1 (en) PYRIDINE DERIVATIVES SUITABLE FOR INHIBITING SODIUM / CALCIUM EXCHANGE SYSTEM
KR940006580A (en) Substituted cyclohexane derivatives for treating diseases
BR9506552A (en) Retroviral integrase inhibition method
IL155965A0 (en) Pharmaceutical compositions containing an imidazole-5-carboxyclic acid derivative
DK0804418T3 (en) Platelet aggregation inhibitors
DE60002558D1 (en) Derivatives of phosphonic acid to inhibit carboxypeptidase B
ES2101342T3 (en) TETRAZOLE DERIVATIVES SUBSTITUTED WITH PHOSPHONE.
WO2000051589A3 (en) VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
MX9806229A (en) BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5'alpha'-REDUCTASES INHIBITORS.
TNSN97092A1 (en) Metal protein enzyme inhibitors and pharmaceutical formulations containing these inhibitors and their pharmacological use and methods and intermediates useful for preparing the aforementioned formulations.
DE69629474D1 (en) ANTIFUNGAL TETRAHYDROFURANE
EP0001715A3 (en) Azetidinone antibiotics and their pharmaceutical formulations and use
KR880013896A (en) Benzofuro [3,2-C] quinoline compound
DE69528984D1 (en) INHIBITION OF LEUKOTRIA BIOSYNTHESIS BY URINE DERIVATIVES
DE69426771D1 (en) DOPAMINE INCORPORATION INHIBITORS FOR TREATING PARKINSON'S SYNDROME
TH43258A (en) Metaloprotase inhibitors

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 660840

Country of ref document: ES